Arcosa Inc (ACA)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 93,700 128,500 147,400 142,700 159,200 286,700 283,200 281,300 245,800 100,400 92,100 73,900 69,600 70,900 78,400 90,900 106,600 117,200 118,700 117,200
Total stockholders’ equity US$ in thousands 2,428,200 2,434,100 2,415,000 2,373,800 2,332,000 2,315,300 2,277,300 2,243,200 2,184,400 2,031,300 1,996,000 1,977,600 1,953,300 1,940,900 1,920,500 1,911,300 1,892,200 1,881,600 1,849,100 1,816,000
ROE 3.86% 5.28% 6.10% 6.01% 6.83% 12.38% 12.44% 12.54% 11.25% 4.94% 4.61% 3.74% 3.56% 3.65% 4.08% 4.76% 5.63% 6.23% 6.42% 6.45%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $93,700K ÷ $2,428,200K
= 3.86%

Arcosa Inc's return on equity (ROE) has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024. The ROE started at 6.45% in March 2020, experienced a slight decline to 6.42% in June 2020, and further decreased to 5.63% by December 2020. This downward trend continued into the first half of 2021, reaching a low of 4.08% by June 30, 2021.

Subsequently, there was a slight improvement in the ROE, with percentages hovering around 4-5% during the second half of 2021 and the first half of 2022. The ROE then saw a significant rise to 11.25% by December 31, 2022, and continued to climb to 12.54% by March 31, 2023, maintaining levels above 12% through the third quarter of 2023.

However, there was a notable decline in ROE to 6.83% by December 31, 2023, followed by further decreases in the range of 3.86% to 5.28% in the subsequent quarters up to December 31, 2024. The ROE performance indicates a mix of periods of growth and decline in profitability relative to shareholders' equity during the analyzed timeframe. It would be important to consider the factors driving these fluctuations in ROE for a more in-depth understanding of Arcosa Inc's financial performance.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
Arcosa Inc
ACA
3.86%
Proto Labs Inc
PRLB
2.23%
Valmont Industries Inc
VMI
22.58%